Ramadan G, Davies B, Kurup V P, Keever-Taylor C A
Medical College of Wisconsin, BMT Program, Milwaukee, WI 53226, USA.
Clin Exp Immunol. 2005 Apr;140(1):81-91. doi: 10.1111/j.1365-2249.2005.02738.x.
Invasive aspergillosis (IA) is a major cause of infection-related mortality in patients with haematological malignancies, especially in recipients of haematopoietic stem cell transplants. We have prepared overlapping pentadecapeptides (11-aa overlap with previous peptide) spanning the entire 427-aa coding region of the Aspergillus allergen, Asp f16 shown previously in mice to induce Th1-type cell responses in vivo and in humans to induce proliferative and cytotoxic CD4(+) T cell responses. Mature dendritic cells (DC) pulsed with a complete pool of peptides were used to generate T cell lines. Two lines from HLA-B3501(+) donors were found to be strongly cytotoxic to autologous Asp f16-peptide pool- and Aspergillus culture extract-pulsed targets after 4-5 weekly primings. Cytotoxic T lymphocyte (CTL) culture supernatant killed Aspergillus conidia, and cells directly killed Aspergillus hyphae. Cytotoxic activity and interferon (IFN)-gamma production were mediated exclusively by CD8(+) T cells in response to pool-pulsed targets. Interleukin (IL)-4 production was not detected. CTL activity was restricted by HLA-B3501 and based on peptide prediction programmes was most probably directed to YFKYTAAAL (YFK), LPLCSAQTW (LPL) and GTRFPQTPM (GTR) in one donor, while only LPL was recognized by CTL from the second donor. Pool-pulsed B3503(+) BLCL but not B3502(+) or B3508(+) BLCL presented peptide to donor no. 1. B3503(+) BLCL presented YFK and to a lesser extent GTR, but not peptide LPL. Our data show that in addition to our previously identified Class II restricted peptide response, DC pulsed with a pentadecapeptide pool from Asp f16 are capable of inducing polyclonal, HLA-Class I-restricted, Aspergillus-specific T cells that may be capable of conferring immunity to IA.
侵袭性曲霉病(IA)是血液系统恶性肿瘤患者感染相关死亡的主要原因,尤其是在造血干细胞移植受者中。我们制备了重叠的十五肽(与先前的肽有11个氨基酸重叠),其跨越曲霉变应原Asp f16的整个427个氨基酸的编码区,先前在小鼠体内已显示该变应原可诱导Th1型细胞反应,在人类中可诱导增殖性和细胞毒性CD4(+) T细胞反应。用一组完整的肽脉冲处理成熟树突状细胞(DC)以产生T细胞系。在每周进行4 - 5次致敏后,发现来自HLA - B3501(+)供体的两个细胞系对自体Asp f16肽库和曲霉培养提取物脉冲处理的靶细胞具有强烈的细胞毒性。细胞毒性T淋巴细胞(CTL)培养上清液可杀死曲霉分生孢子,细胞可直接杀死曲霉菌丝。细胞毒性活性和干扰素(IFN)-γ的产生完全由CD8(+) T细胞介导,以响应肽库脉冲处理的靶细胞。未检测到白细胞介素(IL)-4的产生。CTL活性受HLA - B3501限制,根据肽预测程序,在一个供体中最可能针对YFKYTAAAL(YFK)、LPLCSAQTW(LPL)和GTRFPQTPM(GTR),而第二个供体的CTL仅识别LPL。肽库脉冲处理的B3503(+) B淋巴母细胞系(BLCL)而非B3502(+)或B3508(+) BLCL将肽呈递给供体1。B3503(+) BLCL呈递YFK,在较小程度上呈递GTR,但不呈递肽LPL。我们的数据表明,除了我们先前确定的II类限制性肽反应外,用来自Asp f16的十五肽库脉冲处理的DC能够诱导多克隆的、HLA - I类限制性的、曲霉特异性T细胞,这些T细胞可能能够赋予对IA的免疫力。
Eur J Clin Microbiol Infect Dis. 2012-6-14
Bone Marrow Transplant. 2019-3-13
Curr Opin Immunol. 2014-3-3
Eur J Clin Microbiol Infect Dis. 2012-6-14
Pharmacotherapy. 2003-12
Curr Allergy Asthma Rep. 2003-9